Related Experiment Video
Updated: Jul 2, 2026
11:05
Behavioral Characterization of an Angelman Syndrome Mouse Model
Published on: October 20, 2023
A Drosophila model for Angelman syndrome
Yaning Wu1, Francois V Bolduc, Kimberly Bell
1Section of Molecular Cell and Developmental Biology, Institute for Cell and Molecular Biology, University of Texas, 1 University Station A4800, Austin, TX 78712, USA.
Summary
Researchers developed a Drosophila model for Angelman syndrome, a neurological disorder caused by UBE3A loss-of-function. This fly model helps identify disease-related substrates for UBE3A, aiding in understanding and treating Angelman syndrome.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Angelman syndrome is a rare neurological disorder characterized by severe intellectual disability, motor deficits, and sleep disturbances.
- The condition results from the loss of function of the UBE3A gene, which encodes a ubiquitin ligase crucial for protein degradation.
- Understanding UBE3A's function is key to developing therapeutic strategies for Angelman syndrome.
Purpose of the Study:
- To create a Drosophila melanogaster model for Angelman syndrome to study UBE3A function.
- To validate the functional similarity between human UBE3A and its Drosophila homolog, dube3a.
- To establish a genetic screening platform for identifying UBE3A substrates involved in Angelman syndrome pathogenesis.
Main Methods:
- Generated dube3a null mutants and characterized their behavioral and neurological phenotypes.
- Expressed wild-type and mutant dube3a in the Drosophila nervous system to assess functional consequences.
- Created Drosophila lines overexpressing dube3a in the eye or wing for genetic screens.
Main Results:
- Dube3a expression is high in the Drosophila nervous system, particularly in learning and memory centers.
- dube3a mutants exhibit abnormal locomotion, disrupted circadian rhythms, and impaired long-term memory.
- Overexpression of dube3a in the nervous system causes locomotion defects dependent on its ubiquitin ligase activity.
- Angelman syndrome patient mutations in UBE3A affect conserved residues and act as loss-of-function mutations in dube3a.
- Flies with dube3a overexpression in the eye/wing show morphological defects, indicating a role for dube3a in development.
Conclusions:
- The Drosophila dube3a mutant is a valid and powerful model for studying Angelman syndrome.
- This model system facilitates the identification of critical UBE3A substrates and pathways involved in the disease.
- Findings support the hypothesis that substrate accumulation due to impaired ubiquitination underlies Angelman syndrome pathology.
